Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK V/PETER JUNKER ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   0.9% 0.7% 0.8% 0.7% 0.6% 0.6% 11.3% 11.3%   Credit score (0-100)   90 96 92 94 96 96 21 21   Credit rating   A AA AA AA AA AA BB BB   Credit limit (kDKK)   142.0 245.0 178.3 214.3 240.4 327.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,969 2,225 2,202 2,390 2,511 2,577 0.0 0.0   EBITDA   658 916 766 852 841 860 0.0 0.0   EBIT   488 782 580 695 663 700 0.0 0.0   Pre-tax profit (PTP)   488.2 775.5 578.1 705.1 680.1 699.3 0.0 0.0   Net earnings   379.3 603.9 450.1 556.6 529.2 542.3 0.0 0.0   Pre-tax profit without non-rec. items   488 776 578 705 680 699 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   581 391 542 604 457 497 0.0 0.0   Shareholders equity total   1,167 1,371 1,221 1,378 1,407 1,949 949 949   Interest-bearing liabilities   37.6 39.1 0.0 0.0 0.0 121 0.0 0.0   Balance sheet total (assets)   1,580 2,058 2,198 1,913 1,971 2,654 949 949   Net Debt   -454 -927 -303 -292 -646 -1,175 -949 -949     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,969 2,225 2,202 2,390 2,511 2,577 0.0 0.0   Gross profit growth   10.3% 13.0% -1.0% 8.6% 5.0% 2.6% -100.0% 0.0%   Employees   4 4 4 4 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -25.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,580 2,058 2,198 1,913 1,971 2,654 949 949   Balance sheet change%   -11.8% 30.3% 6.8% -12.9% 3.0% 34.7% -64.2% 0.0%   Added value   658.4 915.7 766.5 851.8 820.3 859.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   25 -323 -36 -95 -325 -120 -497 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   24.8% 35.1% 26.3% 29.1% 26.4% 27.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   29.0% 43.0% 27.5% 34.6% 35.1% 30.5% 0.0% 0.0%   ROI %   38.2% 59.1% 44.1% 54.7% 49.0% 40.6% 0.0% 0.0%   ROE %   35.2% 47.6% 34.7% 42.8% 38.0% 32.3% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   73.9% 66.6% 55.6% 72.0% 71.4% 73.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -69.0% -101.3% -39.6% -34.3% -76.9% -136.6% 0.0% 0.0%   Gearing %   3.2% 2.9% 0.0% 0.0% 0.0% 6.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 15.9% 38.7% 0.0% 0.0% 11.8% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.6 2.0 1.6 2.5 2.9 3.3 0.0 0.0   Current Ratio   1.7 2.1 1.6 2.6 3.0 3.4 0.0 0.0   Cash and cash equivalent   491.9 966.5 303.2 291.8 646.5 1,295.9 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   293.6 704.8 508.3 621.2 795.6 1,297.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   165 229 192 213 273 287 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   165 229 192 213 280 287 0 0   EBIT / employee   122 195 145 174 221 233 0 0   Net earnings / employee   95 151 113 139 176 181 0 0